Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SHMT1 |
| Upstream (Parents) |
|---|
| (<<) EHHADH → SHMT1 |
| (<<) HRSP12 → SHMT1 |
| (<<) APOM → SHMT1 |
| Downstream (Children) |
|---|
| SHMT1 → KIAA1024 (>>) |
| SHMT1 → SCD (>>) |
| SHMT1 → CXCR1 (>>) |
| SHMT1 → GYPE///GYPB (>>) |
| SHMT1 → CTH (>>) |
| SHMT1 → MOSC1 (>>) |
| SHMT1 → GALK1 (>>) |
| SHMT1 → GPR182 (>>) |
| SHMT1 → UGT1A9///UGT1A6///UGT1A8 (>>) |
| SHMT1 → CYP4F11 (>>) |
| SHMT1 → FGFR2 (>>) |
| SHMT1 → AFP (>>) |
| SHMT1 → LGR4 (>>) |
| SHMT1 → PPARGC1A (>>) |
| SHMT1 → TRMT2A (>>) |
| SHMT1 → FH (>>) |
| SHMT1 → BTD (>>) |
| SHMT1 → MANEA (>>) |
| SHMT1 → SHC2 (>>) |
